1.Hemopericardium and Cardiac Tamponade in a Patient Treated with Dabigatran Etexilate.
Filiz KIZILIRMAK ; Haci Murat GUNES ; Ekrem GULER ; Gultekin Gunhan DEMIR ; Oguz KARACA ; Habibe Gamze CANPOLAT
Korean Circulation Journal 2016;46(1):99-101
Dabigatran etexilate is one of the new oral anticoagulants approved to reduce the risk of stroke in patients with atrial fibrillation (AF). A variety of bleeding complications with dabigatran have been reported, but reports of hemopericardium are rare. We described a case of a 66 year-old female patient with non-valvular AF receiving dabigatran etexilate 150 mg twice daily for one year who suffered from hemopericardium. Her laboratory tests performed 1 year prior were normal and her admission tests revealed acute renal failure and elevated international normalized ratio (INR) level (4.79). Urgent pericardiocentesis was followed by improved renal functions and normalized INR. Dabigatran etexilate is a new oral anticoagulant that is increasingly used in daily practice. However, life-threatening complications warrant caution. Elevated INR may be related with overdose but the association of bleeding risk of dabigatran and INR requires further confirmation.
Acute Kidney Injury
;
Anticoagulants
;
Atrial Fibrillation
;
Cardiac Tamponade*
;
Female
;
Hemorrhage
;
Humans
;
International Normalized Ratio
;
Pericardial Effusion*
;
Pericardiocentesis
;
Stroke
;
Dabigatran
2.Comparison of pain and proper sample status according to usage of tenaculum and analgesia: a randomized clinical trial
Cihan COMBA ; Gökhan DEMIRAYAK ; Sakir Volkan ERDOGAN ; Ibrahim KARACA ; Omer DEMIR ; Oguz GULER ; Isa Aykut OZDEMIR
Obstetrics & Gynecology Science 2020;63(4):506-513
Objective:
Colposcopic biopsy is a discomfortable procedure. Additionally, it creates negative influence on sexuality. This study aimed to investigate the relationships among tenaculum, pain perception, and biopsy size during colposcopy.
Methods:
In total, 228 patients who underwent colposcopy-directed biopsy were included, and randomized into 4 groups based on whether analgesic and tenaculum were used and replaced (tenaculum with n=58/without analgesic n=56, no tenaculum replacement with n=57/without analgesic n=57). Lidocaine hydrochloride (40 mg) plus adrenaline (0.025 mg) was administered in the analgesic groups. The pain was assessed using a linear visual analog scale. The biopsy specimen size was measured in millimeters.
Results:
The mean age of the patients was 42.85±8.88 years. The most frequent colposcopy indications were atypical squamous cells of undetermined significance and human papilloma virus-positive results on cervical cytology (30.2%; n=69). Low- and high-grade intraepithelial lesions were noted in 14.91% (n=34) and 10.96% (n=25) women through colposcopy-directed biopsy results, respectively. Tenaculum replacement increased pain perception in the without analgesic group; however, no statistically significant differences were noted between of the groups with and without tenaculum replacement with analgesic. The size and number of biopsy specimens were not associated with tenaculum replacement and analgesic use.
Conclusion
Administration of analgesics decreased discomfort and pain in patients. Tenaculum replacement aided colposcopists in manipulating the cervix. Additionally, administration of analgesics relieved pain in the tenaculum replacement group.Trial RegistrationClinicalTrials.gov Identifier: NCT03279666
3.Comparison of pain and proper sample status according to usage of tenaculum and analgesia: a randomized clinical trial
Cihan COMBA ; Gökhan DEMIRAYAK ; Sakir Volkan ERDOGAN ; Ibrahim KARACA ; Omer DEMIR ; Oguz GULER ; Isa Aykut OZDEMIR
Obstetrics & Gynecology Science 2020;63(4):506-513
Objective:
Colposcopic biopsy is a discomfortable procedure. Additionally, it creates negative influence on sexuality. This study aimed to investigate the relationships among tenaculum, pain perception, and biopsy size during colposcopy.
Methods:
In total, 228 patients who underwent colposcopy-directed biopsy were included, and randomized into 4 groups based on whether analgesic and tenaculum were used and replaced (tenaculum with n=58/without analgesic n=56, no tenaculum replacement with n=57/without analgesic n=57). Lidocaine hydrochloride (40 mg) plus adrenaline (0.025 mg) was administered in the analgesic groups. The pain was assessed using a linear visual analog scale. The biopsy specimen size was measured in millimeters.
Results:
The mean age of the patients was 42.85±8.88 years. The most frequent colposcopy indications were atypical squamous cells of undetermined significance and human papilloma virus-positive results on cervical cytology (30.2%; n=69). Low- and high-grade intraepithelial lesions were noted in 14.91% (n=34) and 10.96% (n=25) women through colposcopy-directed biopsy results, respectively. Tenaculum replacement increased pain perception in the without analgesic group; however, no statistically significant differences were noted between of the groups with and without tenaculum replacement with analgesic. The size and number of biopsy specimens were not associated with tenaculum replacement and analgesic use.
Conclusion
Administration of analgesics decreased discomfort and pain in patients. Tenaculum replacement aided colposcopists in manipulating the cervix. Additionally, administration of analgesics relieved pain in the tenaculum replacement group.Trial RegistrationClinicalTrials.gov Identifier: NCT03279666